Teleflex Incorporated (NYSE:TFX) Holdings Boosted by Handelsbanken Fonder AB

Handelsbanken Fonder AB lifted its holdings in Teleflex Incorporated (NYSE:TFX) by 32.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,900 shares of the medical technology company’s stock after buying an additional 3,400 shares during the period. Handelsbanken Fonder AB’s holdings in Teleflex were worth $3,438,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in TFX. Riverview Trust Co acquired a new stake in Teleflex in the 1st quarter valued at approximately $31,000. Pineridge Advisors LLC bought a new position in shares of Teleflex during the 4th quarter worth approximately $35,000. Canada Pension Plan Investment Board bought a new stake in Teleflex in the second quarter valued at $42,000. Versant Capital Management Inc raised its stake in Teleflex by 20,700.0% during the second quarter. Versant Capital Management Inc now owns 208 shares of the medical technology company’s stock worth $44,000 after acquiring an additional 207 shares in the last quarter. Finally, Blue Trust Inc. lifted its holdings in shares of Teleflex by 78.2% during the second quarter. Blue Trust Inc. now owns 212 shares of the medical technology company’s stock valued at $48,000 after acquiring an additional 93 shares during the period. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Stock Up 0.9 %

TFX opened at $234.95 on Wednesday. Teleflex Incorporated has a one year low of $177.63 and a one year high of $257.85. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.58 and a quick ratio of 1.44. The company has a fifty day moving average price of $239.72 and a 200-day moving average price of $222.12. The firm has a market capitalization of $11.07 billion, a P/E ratio of 37.71, a price-to-earnings-growth ratio of 2.17 and a beta of 1.16.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, August 1st. The medical technology company reported $3.42 EPS for the quarter, topping the consensus estimate of $3.33 by $0.09. Teleflex had a net margin of 8.76% and a return on equity of 14.51%. The business had revenue of $749.70 million during the quarter, compared to analyst estimates of $762.98 million. During the same period in the prior year, the business earned $3.41 EPS. The company’s revenue for the quarter was up .9% on a year-over-year basis. Equities research analysts expect that Teleflex Incorporated will post 13.97 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 16th. Investors of record on Thursday, August 15th were given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.58%. The ex-dividend date was Thursday, August 15th. Teleflex’s dividend payout ratio (DPR) is presently 21.83%.

Wall Street Analyst Weigh In

TFX has been the topic of several research analyst reports. Truist Financial increased their target price on Teleflex from $240.00 to $247.00 and gave the stock a “hold” rating in a report on Monday, August 5th. Royal Bank of Canada upped their price target on Teleflex from $260.00 to $275.00 and gave the stock an “outperform” rating in a research report on Tuesday. Stephens raised their target price on shares of Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a research note on Friday, August 2nd. Finally, Piper Sandler raised shares of Teleflex from a “neutral” rating to an “overweight” rating and increased their price objective for the company from $205.00 to $245.00 in a research report on Monday, July 1st. Three analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, Teleflex has a consensus rating of “Moderate Buy” and an average price target of $267.71.

Insider Buying and Selling at Teleflex

In related news, Director Stuart A. Randle sold 2,674 shares of the business’s stock in a transaction on Friday, August 16th. The shares were sold at an average price of $238.93, for a total value of $638,898.82. Following the sale, the director now owns 5,496 shares in the company, valued at approximately $1,313,159.28. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.43% of the stock is owned by corporate insiders.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.